Trials / Completed
CompletedNCT01436435
The Jetstream (JET) Post-market Registry
Jetstream NAVITUS™ System Endovascular Therapy Post-market Registry (JET)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 241 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The scope of the JET registry to observe long term treatment effects of Jetstream Navitus on various lesions types/morphologies.
Detailed description
* To observe the treatment effects of the Jetstream NAVITUS System in long, occluded, diffuse, thrombotic or calcified lesions in peripheral arterial disease of the common femoral, superficial femoral, or popliteal arteries. * To assess and quantify vessel patency 1 year post atherectomy treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Jetstream Atherectomy System | Atherectomy |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2011-09-19
- Last updated
- 2016-10-19
- Results posted
- 2016-08-26
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01436435. Inclusion in this directory is not an endorsement.